Goniothalamin prevents lipopolysaccharide‐induced acute lung injury and inflammation via TLR‐4/NF‐κB signaling pathway
Journal of Biochemical and Molecular Toxicology · 2023
DOI: 10.1002/jbt.23461 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2023. Verfasst von Gongmin Zou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric, Suzhouwuzhong People's Hospital, Jiangsu, Wuzhong, China. Hauptthemen laut MEDLINE: NF-kappa B, Acute Lung Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Goniothalamin (GTN) is a natural compound isolated from Goniothalamus species. It is a potent anti‐inflammatory agent. However, there is a paucity of scientific data about its toxicity. This study investigated GTN's anti‐inflammatory mechanism and lipopolysaccharide (LPS)‐induced lung injury in mice. Mice were distributed into four groups and injected with GTN intraperitoneally (Dosage—50 and 100 mg/kg). We analyzed the wet/dry weight ratio, infiltrated inflammatory cell count, myeloperoxidase (MPO) activity, and histopathological changes in the lung tissues of the mice. Results revealed GTN alleviated LPS‐induced inflammation in mice. Western Blot and enzyme‐linked immunosorbent assay techniques were used to investigate the effect of GTN on pro‐inflammatory cytokines and proteins involved in the MAPK and nuclear factor‐B (NF‐κB) signaling pathways. Cytokines (macrophage migration inhibitory factor, interleukin [IL]‐13, IL‐6, TNF‐α, and IL‐1β) were inhibited by GTN. However, IL‐10 was upregulated. Western blot analysis indicated that GTN suppressed the phosphorylation of jun N‐terminal kinase, nuclear factor NF‐kappa‐B p65, I‐kappa‐B, extracellular signal‐regulated kinases, NF‐κB, and p38. GTN also suppressed the expression of TLR‐4 protein, thereby, inhibiting MAPK and NF‐κB signaling pathways. Thus, GTN can effectively prevent and cure acute lung injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric, Suzhouwuzhong People's Hospital, Jiangsu, Wuzhong, China.
- Department of Respiratory Disease, Chinese PLA General Hospital of Central Theater Command, Hubei, Wuhan, China.
- Department of Critical Care Medicine, Wuhan Fifth Hospital, Hubei Province, Hubei, Wuhan, China.
Zitieren
APA
Zou, G., Li, L., Gao, L., Zhou, Y., Ma, Z., & Hu, Z. (2023). Goniothalamin prevents lipopolysaccharide‐induced acute lung injury and inflammation via TLR‐4/NF‐κB signaling pathway. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23461
Vancouver
Zou G, Li L, Gao L, Zhou Y, Ma Z, Hu Z. Goniothalamin prevents lipopolysaccharide‐induced acute lung injury and inflammation via TLR‐4/NF‐κB signaling pathway. Journal of Biochemical and Molecular Toxicology. 2023. doi:10.1002/jbt.23461
BibTeX
@article{Zou2023,
author = {Zou, Gongmin and Li, Long and Gao, LanPing and Zhou, YingHong and Ma, ZeNan and Hu, Zekun},
title = {Goniothalamin prevents lipopolysaccharide‐induced acute lung injury and inflammation via TLR‐4/NF‐κB signaling pathway},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2023},
doi = {10.1002/jbt.23461}
}
EUVIMED